ESC 365 - Efficacy and safety of ambulatory, weekly, high-intensity intravenous diuretic strategy for congestion-refractory heart failure patients: insights from the DEA-HF prospective randomized clinical trial

ESC Premium Access

Efficacy and safety of ambulatory, weekly, high-intensity intravenous diuretic strategy for congestion-refractory heart failure patients: insights from the DEA-HF prospective randomized clinical trial

Session: Telemonitoring and multidisciplinary care in heart failure

Topic: Pharmacotherapy

Speaker: Mr A. Gruber (Haifa, IL)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Mr Amit Gruber

Haifa (Israel)

0 follower

8 more presentations in this session

Heart failure hospitalization reduction and long-term safety with remote pulmonary artery pressure monitoring: results of the CardioMEMS HF System OUS Post-Market Study

Speaker: Professor F. Roubille (Montpellier, FR)

Empowering patients with heart failure: a digital health solution improved self-care and metabolic outcomes in a randomized controlled trial

Speaker: Professor D. Arnar (Reykjavik, IS)

The effects of a dyadic empowerment-based heart failure management (De-HF) programme on self-care and HRQL : a randomized controlled trial

Speaker: Doctor D. Yu (Hong Kong, HK)

Delivering remote monitoring, through primary care, to patients with chronic heart failure

Speaker: Doctor D. Bailey (IE)

Automated digital counselling with social network support for chronic heart failure fails to improve health status but promotes health-related quality of life: ODYSSEE-vCHAT pilot trial

Speaker: Associate Professor R. Nolan (Toronto, CA)

Access the full session

Telemonitoring and multidisciplinary care in heart failure

Speakers: Mr A. Gruber, Professor F. Roubille, Professor D. Arnar, Doctor D. Yu, Doctor D. Bailey...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources